208 related articles for article (PubMed ID: 19555752)
1. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
Hamid KA; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2009 Sep; 379(1):100-8. PubMed ID: 19555752
[TBL] [Abstract][Full Text] [Related]
2. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
3. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
4. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
5. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.
Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2016 Feb; 499(1-2):58-66. PubMed ID: 26707414
[TBL] [Abstract][Full Text] [Related]
6. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Takahashi Y; Kondo H; Yasuda T; Watanabe T; Kobayashi S; Yokohama S
Int J Pharm; 2002 Oct; 246(1-2):85-94. PubMed ID: 12270611
[TBL] [Abstract][Full Text] [Related]
7. Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat.
Yan C; Gu J; Lv Y; Shi W; Jing H
Drug Deliv Transl Res; 2017 Jun; 7(3):408-415. PubMed ID: 28303451
[TBL] [Abstract][Full Text] [Related]
8. The effect of wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats.
Hamid KA; Lin Y; Gao Y; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2009 Nov; 32(11):1898-905. PubMed ID: 19881305
[TBL] [Abstract][Full Text] [Related]
9. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
Onishi H; Imura Y; Uchida M; Machida Y
Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
[TBL] [Abstract][Full Text] [Related]
10. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
[TBL] [Abstract][Full Text] [Related]
11. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
12. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
13. Improvement of pulmonary absorption of poorly absorbable macromolecules by hydroxypropyl-β-cyclodextrin grafted polyethylenimine (HP-β-CD-PEI) in rats.
Zhang H; Huang X; Sun Y; Lu G; Wang K; Wang Z; Xing J; Gao Y
Int J Pharm; 2015 Jul; 489(1-2):294-303. PubMed ID: 25959121
[TBL] [Abstract][Full Text] [Related]
14. Beta-cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs.
Oda M; Saitoh H; Kobayashi M; Aungst BJ
Int J Pharm; 2004 Aug; 280(1-2):95-102. PubMed ID: 15265550
[TBL] [Abstract][Full Text] [Related]
15. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.
Shono Y; Nishihara H; Matsuda Y; Furukawa S; Okada N; Fujita T; Yamamoto A
J Pharm Sci; 2004 Apr; 93(4):877-85. PubMed ID: 14999725
[TBL] [Abstract][Full Text] [Related]
16. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.
Lin Y; Shen Q; Katsumi H; Okada N; Fujita T; Jiang X; Yamamoto A
Biol Pharm Bull; 2007 Jul; 30(7):1301-7. PubMed ID: 17603171
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmaceutical excipients on membrane permeability in rat small intestine.
Takizawa Y; Kishimoto H; Nakagawa M; Sakamoto N; Tobe Y; Furuya T; Tomita M; Hayashi M
Int J Pharm; 2013 Sep; 453(2):363-70. PubMed ID: 23742974
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine.
Koga K; Kawashima S; Murakami M
Eur J Pharm Biopharm; 2002 Nov; 54(3):311-8. PubMed ID: 12445561
[TBL] [Abstract][Full Text] [Related]
20. Improvement of pulmonary absorptions of poorly absorbable drugs using Gelucire 44/14 as an absorption enhancer.
Zhang H; Huang X; Mi J; Huo Y; Wang G; Xing J; Gao Y
J Pharm Pharmacol; 2014 Oct; 66(10):1410-20. PubMed ID: 24849123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
